DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Video Credit: ANI
Published on May 8, 2021 - Duration: 02:44s

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients.

While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG).

The drug will be of immense benefit to the people suffering from COVID-19.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
Scoring a new milestone, Bhubaneswar has become the first city to achieve 100 per cent COVID-19 vaccination
Credit: DNA - Published 2 hours ago

The third wave of COVID will likely hit India this month as daily infections tally will go up to 100,000 in the best-case scenario, researchers said
Credit: DNA - Published 3 hours ago

Tests at four major railway stations in England and on intercity train services revealed no traces of COVID-19, National Rail has said.
3 hours ago • Sky News
According to a report, India is likely to see a rise in Covid-19 infections building into a third wave -- though smaller -- that may peak in October. The next..
Credit: IndiaTimes - Published 4 hours ago



Related videos from verified sources

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News 02:34
Video credit: Oneindia - Published on May 17, 2021 

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials 01:59
Video credit: ANI - Published on May 9, 2021 

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen 03:24
Video credit: HT Digital Content - Published on May 8, 2021 

You might like